Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years)

Zoledronate 5 mg every 18 months reduces fragility fractures in women over 65 with osteopenia (NNT = 15 over 6 years) is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central